Fri Sep 20 12:45:32 UTC 2024: ## BioLargo (BLGO) Lags Behind Peers in Chemicals & Allied Products Industry: MarketBeat Analysis

**Westminster, CA – September 20, 2024** – BioLargo, Inc. (NASDAQ: BLGO), a developer of environmental technologies, faces challenges in the competitive “Chemicals & Allied Products” industry, according to a recent analysis by MarketBeat News. While BioLargo offers solutions for water and air quality control, the company falls short of its peers in terms of revenue, earnings, and projected growth potential.

MarketBeat’s comparative analysis reveals that BioLargo’s peers generate significantly higher revenue and earnings per share. While BioLargo trades at a lower price-to-earnings ratio, suggesting affordability, analysts expect its peers to experience greater growth in the future.

Institutional investor interest in BioLargo also lags behind the industry average. Only 0.0% of BioLargo shares are held by institutional investors, compared to 68.3% for the industry as a whole. This indicates that large financial institutions are less confident in BioLargo’s long-term growth prospects.

Further, BioLargo exhibits significantly lower volatility compared to its peers. The company’s beta of 0.2 suggests its stock price is 80% less volatile than the S&P 500, while its peers have a beta of 1.81, indicating 81% higher volatility.

Overall, BioLargo’s performance across key metrics falls behind its peers. While the company provides innovative solutions for environmental challenges, investors may need to consider its limited growth potential and lower institutional interest before investing.

**To receive daily updates on BioLargo and its competitors, sign up for MarketBeat.com’s free email newsletter.**

**Critical Contrast:** This analysis also highlights the contrasting performance of two other companies in the sector: LianBio (NASDAQ: LIAN) and Halberd (OTCMKTS: HALB).

**Disclaimer:** This news article is based on information provided by MarketBeat News and should not be considered investment advice.

Read More